Home Our Speciality The Doctor Who We Help What To Expect Contact Us
Neuropsychology
1. What Is Neuropsychology
2. Neuropsychological Evaluation
3. Reason For Evaluation
4. Neuropsychological Treatment
Neuropsychological Conditions
Alzheimer's Disease & Other Dementias
Attention Deficit/ Hyperactivity Disorder
Brain Tumors & Cancer
Endocrine Disorders
Epilepsy & Seizure Disorders
Klinefelter Syndrome & Other Sex Chromosome Abnormalities
Learning Disorders: Reading (dyslexia), Math & Writing
Motor Neuron Diseases
Pervasive Developmental Disoders- Autism & Asperger's Disorder
Traumatic Brain Injury & Sports Concussion
Domain Assessed
Academic Achievement
Adaptive Functioning
Attention
Executive Functioning
Intellectual Functioning
Memory
Motor Speed & Coordination
Personality
Speech & Language
Visuoconstruction Abilities

NEWS

[2010-03-04]
Healthsource-Health Care Information about Child seizure study oldest drug works

Health Care Information about Child seizure study oldest drug works Reuters

BOSTON (Reuters) –
A large-scale comparative test of three anti-epilepsy drugs found the oldest was best for treating childhood absence epilepsy, in which youngsters often stare into space for up to 20 seconds many times a day.

Ethosuximide, available since the 1950s, offered the best protection for the condition. Lamotrigine fared the worst, the researchers reported in the New England Journal of Medicine.

A third treatment, valproic acid, worked nearly as well as ethosuximide, but interfered with concentration.

The generic drugs used in the study were made by Pfizer Inc. (Ethosuximide), GlaxoSmithKline Plc (Lamotrigine) and Abbott Laboratories (valproic acid).

“The older drug gives you better seizure control combined with fewer attention problems,” Dr. Tracy Glauser of Cincinnati Children’s Hospital in Ohio, who led the study, said in a telephone interview.

The study is the first to conclusively compare drug treatments for childhood absence epilepsy, the most common form of childhood seizures.


The condition usually begins between ages 4 and 8 in children with no other health problems. It is sometimes called petit mal epilepsy.

The study looked at 446 youngsters treated at 32 centers across the United States.

After four months of therapy, 58 percent of the children getting valproic acid and 53 percent of those getting ethosuximide were free of seizures, compared to just 29 percent given lamotrigine.

But too many valproic acid recipients continued to experience problems paying attention.

So the winner is ethosuximide, Dr. Eileen Vining of the Johns Hopkins School of Medicine in Baltimore said in a commentary. “This is an age when the newest therapy is assumed to be more effective and better tolerated than older therapies,” she wrote.

Glauser said the researchers also discovered that even though there may be no outward evidence of seizures and drug therapy appears successful, EEG brainwave tests show they can be occurring.

“EEG studies are necessary to know if the kids are seizure free (because) the longer they have these types of seizures, the higher their risk of developing other types of seizures and, we think, the harder it is to control,” Glauser said.

In addition, if a child has problems paying attention before treatment, drugs may not cure that.

“We still have a lot of room for improvement,” he said.

Evaluations for Adults

Adults request neuropsychological evaluations for ...
more

Evaluations for Children

In the majority of cases children are brought for ...
more

Lectures & Seminars

Dr. Rozenblatt is available for speaking engagemen...
more
Subscribe
Address
Shahal Rozenblatt, Ph.D.
Clinical Neuropsychologist
Advanced Psychological Assessment, P.C.

50 Karl Avenue, Suite 104
Smithtown, NY 11787

137 East 36 Street, Suite 4
New York, NY 10016

Tel: 866-840-9790
Site Index | Table of Contents | Links | Disclaimer

© 2006 Advancedpsy

neuro@advancedpsy.com | Legal Disclaimer | Notice of Privacy Practices

Partner